Onivyde for the therapy of multiple solid tumors
Haijun Zhang Department of Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People’s Republic of China Abstract: Drug delivery system based on nanobiotechnology can improve the pharmacokinetics and therapeutic index of chemotherapeutic agents, which has revoluti...
Main Author: | Zhang H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-05-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/onivyde-for-the-therapy-of-multiple-solid-tumors-peer-reviewed-article-OTT |
Similar Items
-
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
by: Danielle C. Glassman, et al.
Published: (2018-06-01) -
Bifunctional Aptamer Drug Carrier Enabling Selective and Efficient Incorporation of an Approved Anticancer Drug Irinotecan to Fibrin Gels
by: Hiroto Fujita, et al.
Published: (2020-12-01) -
Therapeutic Dose Response of Acoustic Cluster Therapy in Combination With Irinotecan for the Treatment of Human Colon Cancer in Mice
by: Nigel Bush, et al.
Published: (2019-11-01) -
A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver
by: Marites P. Melancon, et al.
Published: (2021-01-01) -
Liposomal Irinotecan for Treatment of Colorectal Cancer in a Preclinical Model
by: Jiao-Ren Huang, et al.
Published: (2019-02-01)